TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
hsa00310	Lysine degradation	0.0149994269967464	-4.19974327882648	52	1	0.5	2	6908	5352	PLOD2
ko00310	Lysine degradation	0.0149994269967464	-4.19974327882648	52	1	0.5	2	6908	5352	PLOD2
hsa05220	Chronic myeloid leukemia	0.0210247586660045	-3.86205455161923	73	1	0.5	2	6908	2122	MECOM
ko05220	Chronic myeloid leukemia	0.0210247586660045	-3.86205455161923	73	1	0.5	2	6908	2122	MECOM
hsa04010	MAPK signaling pathway	0.072469970587099	-2.62458300172416	255	1	0.5	2	6908	2122	MECOM
ko04010	MAPK signaling pathway	0.072469970587099	-2.62458300172416	255	1	0.5	2	6908	2122	MECOM
hsa05200	Pathways in cancer	0.111644288257804	-2.19243745957014	397	1	0.5	2	6908	2122	MECOM
hsa00770	Pantothenate and CoA biosynthesis	0.999999999975989	-2.40114081444809e-11	18	0	0	2	6908
ko00770	Pantothenate and CoA biosynthesis	0.999999999975989	-2.40114081444809e-11	18	0	0	2	6908
hsa00511	Other glycan degradation	0.999999999975989	-2.40114081444809e-11	18	0	0	2	6908
ko00511	Other glycan degradation	0.999999999975989	-2.40114081444809e-11	18	0	0	2	6908
hsa04070	Phosphatidylinositol signaling system	0.999999999978772	-2.12275908385417e-11	98	0	0	2	6908
hsa04750	Inflammatory mediator regulation of TRP channels	0.999999999978772	-2.12275908385417e-11	98	0	0	2	6908
ko04750	Inflammatory mediator regulation of TRP channels	0.999999999978772	-2.12275908385417e-11	98	0	0	2	6908
ko04070	Phosphatidylinositol signaling system	0.999999999978772	-2.12275908385417e-11	98	0	0	2	6908
hsa03450	Non-homologous end-joining	0.999999999981234	-1.8766268421452e-11	13	0	0	2	6908
hsa00061	Fatty acid biosynthesis	0.999999999981234	-1.8766268421452e-11	13	0	0	2	6908
ko03450	Non-homologous end-joining	0.999999999981234	-1.8766268421452e-11	13	0	0	2	6908
ko00061	Fatty acid biosynthesis	0.999999999981234	-1.8766268421452e-11	13	0	0	2	6908
ko04144	Endocytosis	0.999999999981583	-1.84171410760881e-11	258	0	0	2	6908
hsa05166	HTLV-I infection	0.999999999981583	-1.84171410760881e-11	258	0	0	2	6908
hsa04144	Endocytosis	0.999999999981583	-1.84171410760881e-11	258	0	0	2	6908
ko05166	HTLV-I infection	0.999999999981583	-1.84171410760881e-11	258	0	0	2	6908
hsa00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	0.999999999982015	-1.79849106968059e-11	25	0	0	2	6908
ko00592	alpha-Linolenic acid metabolism	0.999999999982015	-1.79849106968059e-11	25	0	0	2	6908
hsa00592	alpha-Linolenic acid metabolism	0.999999999982015	-1.79849106968059e-11	25	0	0	2	6908
hsa00062	Fatty acid elongation	0.999999999982015	-1.79849106968059e-11	25	0	0	2	6908
ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	0.999999999982015	-1.79849106968059e-11	25	0	0	2	6908
ko00062	Fatty acid elongation	0.999999999982015	-1.79849106968059e-11	25	0	0	2	6908
hsa05213	Endometrial cancer	0.999999999982369	-1.76313725717882e-11	52	0	0	2	6908
hsa05320	Autoimmune thyroid disease	0.999999999982369	-1.76313725717882e-11	52	0	0	2	6908
ko05320	Autoimmune thyroid disease	0.999999999982369	-1.76313725717882e-11	52	0	0	2	6908
ko05213	Endometrial cancer	0.999999999982369	-1.76313725717882e-11	52	0	0	2	6908
hsa04210	Apoptosis	0.999999999984357	-1.56428959954651e-11	85	0	0	2	6908
ko04210	Apoptosis	0.999999999984357	-1.56428959954651e-11	85	0	0	2	6908
ko05132	Salmonella infection	0.999999999984357	-1.56428959954651e-11	85	0	0	2	6908
hsa05132	Salmonella infection	0.999999999984357	-1.56428959954651e-11	85	0	0	2	6908
hsa04911	Insulin secretion	0.999999999984357	-1.56428959954651e-11	85	0	0	2	6908
ko00900	Terpenoid backbone biosynthesis	0.999999999984421	-1.55785993592126e-11	22	0	0	2	6908
hsa00900	Terpenoid backbone biosynthesis	0.999999999984421	-1.55785993592126e-11	22	0	0	2	6908
hsa05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	0.999999999985035	-1.4964795963285e-11	74	0	0	2	6908
ko04260	Cardiac muscle contraction	0.999999999985035	-1.4964795963285e-11	74	0	0	2	6908
hsa04971	Gastric acid secretion	0.999999999985035	-1.4964795963285e-11	74	0	0	2	6908
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	0.999999999985035	-1.4964795963285e-11	74	0	0	2	6908
hsa04260	Cardiac muscle contraction	0.999999999985035	-1.4964795963285e-11	74	0	0	2	6908
hsa00980	Metabolism of xenobiotics by cytochrome P450	0.999999999985035	-1.4964795963285e-11	74	0	0	2	6908
ko04971	Gastric acid secretion	0.999999999985035	-1.4964795963285e-11	74	0	0	2	6908
ko00980	Metabolism of xenobiotics by cytochrome P450	0.999999999985035	-1.4964795963285e-11	74	0	0	2	6908
ko04120	Ubiquitin mediated proteolysis	0.999999999985203	-1.47975141796992e-11	137	0	0	2	6908
hsa04120	Ubiquitin mediated proteolysis	0.999999999985203	-1.47975141796992e-11	137	0	0	2	6908
ko00740	Riboflavin metabolism	0.99999999998542	-1.45797594475157e-11	4	0	0	2	6908
hsa00290	Valine, leucine and isoleucine biosynthesis	0.99999999998542	-1.45797594475157e-11	4	0	0	2	6908
ko00471	D-Glutamine and D-glutamate metabolism	0.99999999998542	-1.45797594475157e-11	4	0	0	2	6908
hsa00471	D-Glutamine and D-glutamate metabolism	0.99999999998542	-1.45797594475157e-11	4	0	0	2	6908
hsa00740	Riboflavin metabolism	0.99999999998542	-1.45797594475157e-11	4	0	0	2	6908
ko00290	Valine, leucine and isoleucine biosynthesis	0.99999999998542	-1.45797594475157e-11	4	0	0	2	6908
hsa00730	Thiamine metabolism	0.99999999998542	-1.45797594475157e-11	4	0	0	2	6908
ko00730	Thiamine metabolism	0.99999999998542	-1.45797594475157e-11	4	0	0	2	6908
ko00052	Galactose metabolism	0.999999999986396	-1.36044100077892e-11	30	0	0	2	6908
hsa05310	Asthma	0.999999999986396	-1.36044100077892e-11	30	0	0	2	6908
ko00020	Citrate cycle (TCA cycle)	0.999999999986396	-1.36044100077892e-11	30	0	0	2	6908
hsa00052	Galactose metabolism	0.999999999986396	-1.36044100077892e-11	30	0	0	2	6908
hsa00020	Citrate cycle (TCA cycle)	0.999999999986396	-1.36044100077892e-11	30	0	0	2	6908
ko05310	Asthma	0.999999999986396	-1.36044100077892e-11	30	0	0	2	6908
ko04620	Toll-like receptor signaling pathway	0.999999999986996	-1.30038235496462e-11	106	0	0	2	6908
hsa04620	Toll-like receptor signaling pathway	0.999999999986996	-1.30038235496462e-11	106	0	0	2	6908
ko04722	Neurotrophin signaling pathway	0.999999999987209	-1.2791027460303e-11	120	0	0	2	6908
hsa00190	Oxidative phosphorylation	0.999999999987209	-1.2791027460303e-11	120	0	0	2	6908
hsa04270	Vascular smooth muscle contraction	0.999999999987209	-1.2791027460303e-11	120	0	0	2	6908
ko04270	Vascular smooth muscle contraction	0.999999999987209	-1.2791027460303e-11	120	0	0	2	6908
ko04071	Sphingolipid signaling pathway	0.999999999987209	-1.2791027460303e-11	120	0	0	2	6908
hsa04722	Neurotrophin signaling pathway	0.999999999987209	-1.2791027460303e-11	120	0	0	2	6908
hsa04071	Sphingolipid signaling pathway	0.999999999987209	-1.2791027460303e-11	120	0	0	2	6908
ko00190	Oxidative phosphorylation	0.999999999987209	-1.2791027460303e-11	120	0	0	2	6908
ko04668	TNF signaling pathway	0.999999999987334	-1.26655898768056e-11	110	0	0	2	6908
hsa04668	TNF signaling pathway	0.999999999987334	-1.26655898768056e-11	110	0	0	2	6908
hsa04110	Cell cycle	0.999999999987353	-1.26469624703307e-11	124	0	0	2	6908
ko04110	Cell cycle	0.999999999987353	-1.26469624703307e-11	124	0	0	2	6908
ko04610	Complement and coagulation cascades	0.999999999987414	-1.25862106110583e-11	69	0	0	2	6908
ko03320	PPAR signaling pathway	0.999999999987414	-1.25862106110583e-11	69	0	0	2	6908
hsa03320	PPAR signaling pathway	0.999999999987414	-1.25862106110583e-11	69	0	0	2	6908
hsa04610	Complement and coagulation cascades	0.999999999987414	-1.25862106110583e-11	69	0	0	2	6908
ko00330	Arginine and proline metabolism	0.99999999998761	-1.2390167451054e-11	49	0	0	2	6908
hsa05144	Malaria	0.99999999998761	-1.2390167451054e-11	49	0	0	2	6908
ko00510	N-Glycan biosynthesis	0.99999999998761	-1.2390167451054e-11	49	0	0	2	6908
hsa00330	Arginine and proline metabolism	0.99999999998761	-1.2390167451054e-11	49	0	0	2	6908
hsa00510	N-Glycan biosynthesis	0.99999999998761	-1.2390167451054e-11	49	0	0	2	6908
ko05144	Malaria	0.99999999998761	-1.2390167451054e-11	49	0	0	2	6908
hsa05030	Cocaine addiction	0.99999999998761	-1.2390167451054e-11	49	0	0	2	6908
ko05030	Cocaine addiction	0.99999999998761	-1.2390167451054e-11	49	0	0	2	6908
hsa04940	Type I diabetes mellitus	0.999999999987789	-1.22112504298815e-11	43	0	0	2	6908
ko04940	Type I diabetes mellitus	0.999999999987789	-1.22112504298815e-11	43	0	0	2	6908
ko04062	Chemokine signaling pathway	0.999999999987931	-1.2069345739843e-11	187	0	0	2	6908
hsa04062	Chemokine signaling pathway	0.999999999987931	-1.2069345739843e-11	187	0	0	2	6908
ko05016	Huntington's disease	0.999999999987931	-1.2069345739843e-11	187	0	0	2	6908
hsa05016	Huntington's disease	0.999999999987931	-1.2069345739843e-11	187	0	0	2	6908
hsa05146	Amoebiasis	0.999999999988136	-1.18644068365387e-11	107	0	0	2	6908
ko05146	Amoebiasis	0.999999999988136	-1.18644068365387e-11	107	0	0	2	6908
ko04370	VEGF signaling pathway	0.999999999988246	-1.17539265538473e-11	61	0	0	2	6908
hsa04370	VEGF signaling pathway	0.999999999988246	-1.17539265538473e-11	61	0	0	2	6908
hsa04976	Bile secretion	0.999999999988266	-1.17343608110497e-11	71	0	0	2	6908
hsa05218	Melanoma	0.999999999988266	-1.17343608110497e-11	71	0	0	2	6908
ko04976	Bile secretion	0.999999999988266	-1.17343608110497e-11	71	0	0	2	6908
hsa00562	Inositol phosphate metabolism	0.999999999988266	-1.17343608110497e-11	71	0	0	2	6908
ko00562	Inositol phosphate metabolism	0.999999999988266	-1.17343608110497e-11	71	0	0	2	6908
ko05218	Melanoma	0.999999999988266	-1.17343608110497e-11	71	0	0	2	6908
hsa04918	Thyroid hormone synthesis	0.999999999988266	-1.17343608110497e-11	71	0	0	2	6908
ko04918	Thyroid hormone synthesis	0.999999999988266	-1.17343608110497e-11	71	0	0	2	6908
hsa04150	mTOR signaling pathway	0.999999999988358	-1.16416719607481e-11	60	0	0	2	6908
ko04150	mTOR signaling pathway	0.999999999988358	-1.16416719607481e-11	60	0	0	2	6908
hsa04730	Long-term depression	0.999999999988358	-1.16416719607481e-11	60	0	0	2	6908
ko04730	Long-term depression	0.999999999988358	-1.16416719607481e-11	60	0	0	2	6908
ko03410	Base excision repair	0.999999999988519	-1.14810217810655e-11	33	0	0	2	6908
hsa03410	Base excision repair	0.999999999988519	-1.14810217810655e-11	33	0	0	2	6908
ko05206	MicroRNAs in cancer	0.999999999988568	-1.14317004213521e-11	297	0	0	2	6908
hsa05206	MicroRNAs in cancer	0.999999999988568	-1.14317004213521e-11	297	0	0	2	6908
hsa05203	Viral carcinogenesis	0.999999999988648	-1.13516304646108e-11	205	0	0	2	6908
ko05203	Viral carcinogenesis	0.999999999988648	-1.13516304646108e-11	205	0	0	2	6908
ko05130	Pathogenic Escherichia coli infection	0.999999999988663	-1.1337226188228e-11	55	0	0	2	6908
hsa05134	Legionellosis	0.999999999988663	-1.1337226188228e-11	55	0	0	2	6908
hsa05150	Staphylococcus aureus infection	0.999999999988663	-1.1337226188228e-11	55	0	0	2	6908
ko05150	Staphylococcus aureus infection	0.999999999988663	-1.1337226188228e-11	55	0	0	2	6908
hsa05130	Pathogenic Escherichia coli infection	0.999999999988663	-1.1337226188228e-11	55	0	0	2	6908
ko05217	Basal cell carcinoma	0.999999999988663	-1.1337226188228e-11	55	0	0	2	6908
ko05134	Legionellosis	0.999999999988663	-1.1337226188228e-11	55	0	0	2	6908
hsa05217	Basal cell carcinoma	0.999999999988663	-1.1337226188228e-11	55	0	0	2	6908
hsa04141	Protein processing in endoplasmic reticulum	0.999999999988883	-1.11165083215015e-11	168	0	0	2	6908
ko04141	Protein processing in endoplasmic reticulum	0.999999999988883	-1.11165083215015e-11	168	0	0	2	6908
hsa00830	Retinol metabolism	0.999999999989253	-1.07469940471795e-11	65	0	0	2	6908
ko05321	Inflammatory bowel disease (IBD)	0.999999999989253	-1.07469940471795e-11	65	0	0	2	6908
ko00830	Retinol metabolism	0.999999999989253	-1.07469940471795e-11	65	0	0	2	6908
hsa05214	Glioma	0.999999999989253	-1.07469940471795e-11	65	0	0	2	6908
ko05214	Glioma	0.999999999989253	-1.07469940471795e-11	65	0	0	2	6908
hsa05321	Inflammatory bowel disease (IBD)	0.999999999989253	-1.07469940471795e-11	65	0	0	2	6908
ko03040	Spliceosome	0.999999999989526	-1.04735966535881e-11	132	0	0	2	6908
hsa03040	Spliceosome	0.999999999989526	-1.04735966535881e-11	132	0	0	2	6908
hsa04014	Ras signaling pathway	0.99999999998965	-1.03495870727721e-11	227	0	0	2	6908
ko04145	Phagosome	0.999999999990099	-9.90081860897593e-12	152	0	0	2	6908
hsa04145	Phagosome	0.999999999990099	-9.90081860897593e-12	152	0	0	2	6908
ko05160	Hepatitis C	0.999999999990172	-9.8282782194821e-12	133	0	0	2	6908
hsa03010	Ribosome	0.999999999990172	-9.8282782194821e-12	133	0	0	2	6908
ko03010	Ribosome	0.999999999990172	-9.8282782194821e-12	133	0	0	2	6908
hsa05160	Hepatitis C	0.999999999990172	-9.8282782194821e-12	133	0	0	2	6908
ko04666	Fc gamma R-mediated phagocytosis	0.999999999990577	-9.42330290404705e-12	92	0	0	2	6908
hsa04666	Fc gamma R-mediated phagocytosis	0.999999999990577	-9.42330290404705e-12	92	0	0	2	6908
ko04724	Glutamatergic synapse	0.999999999990624	-9.37609706671769e-12	114	0	0	2	6908
hsa04724	Glutamatergic synapse	0.999999999990624	-9.37609706671769e-12	114	0	0	2	6908
hsa02010	ABC transporters	0.999999999990687	-9.31341337601435e-12	44	0	0	2	6908
ko00071	Fatty acid degradation	0.999999999990687	-9.31341337601435e-12	44	0	0	2	6908
ko02010	ABC transporters	0.999999999990687	-9.31341337601435e-12	44	0	0	2	6908
hsa03050	Proteasome	0.999999999990687	-9.31341337601435e-12	44	0	0	2	6908
ko04962	Vasopressin-regulated water reabsorption	0.999999999990687	-9.31341337601435e-12	44	0	0	2	6908
hsa00071	Fatty acid degradation	0.999999999990687	-9.31341337601435e-12	44	0	0	2	6908
hsa00970	Aminoacyl-tRNA biosynthesis	0.999999999990687	-9.31341337601435e-12	44	0	0	2	6908
hsa04962	Vasopressin-regulated water reabsorption	0.999999999990687	-9.31341337601435e-12	44	0	0	2	6908
ko03050	Proteasome	0.999999999990687	-9.31341337601435e-12	44	0	0	2	6908
ko00970	Aminoacyl-tRNA biosynthesis	0.999999999990687	-9.31341337601435e-12	44	0	0	2	6908
hsa04740	Olfactory transduction	0.999999999990828	-9.17177271630987e-12	404	0	0	2	6908
ko04740	Olfactory transduction	0.999999999990828	-9.17177271630987e-12	404	0	0	2	6908
hsa03030	DNA replication	0.99999999999084	-9.16012090059425e-12	36	0	0	2	6908
ko03030	DNA replication	0.99999999999084	-9.16012090059425e-12	36	0	0	2	6908
hsa05340	Primary immunodeficiency	0.99999999999084	-9.16012090059425e-12	36	0	0	2	6908
ko00040	Pentose and glucuronate interconversions	0.99999999999084	-9.16012090059425e-12	36	0	0	2	6908
hsa00040	Pentose and glucuronate interconversions	0.99999999999084	-9.16012090059425e-12	36	0	0	2	6908
ko05340	Primary immunodeficiency	0.99999999999084	-9.16012090059425e-12	36	0	0	2	6908
ko01200	Carbon metabolism	0.999999999991044	-8.95624048015409e-12	113	0	0	2	6908
hsa01200	Carbon metabolism	0.999999999991044	-8.95624048015409e-12	113	0	0	2	6908
hsa04530	Tight junction	0.999999999991489	-8.5113207714399e-12	138	0	0	2	6908
ko04530	Tight junction	0.999999999991489	-8.5113207714399e-12	138	0	0	2	6908
hsa01100	Metabolic pathways	0.999999999991492	-8.50826353815393e-12	1214	0	0	2	6908
hsa04122	Sulfur relay system	0.999999999991766	-8.2341336772683e-12	10	0	0	2	6908
ko00920	Sulfur metabolism	0.999999999991766	-8.2341336772683e-12	10	0	0	2	6908
hsa00072	Synthesis and degradation of ketone bodies	0.999999999991766	-8.2341336772683e-12	10	0	0	2	6908
ko04122	Sulfur relay system	0.999999999991766	-8.2341336772683e-12	10	0	0	2	6908
hsa00920	Sulfur metabolism	0.999999999991766	-8.2341336772683e-12	10	0	0	2	6908
ko00072	Synthesis and degradation of ketone bodies	0.999999999991766	-8.2341336772683e-12	10	0	0	2	6908
ko00561	Glycerolipid metabolism	0.99999999999177	-8.22988218914834e-12	59	0	0	2	6908
hsa00561	Glycerolipid metabolism	0.99999999999177	-8.22988218914834e-12	59	0	0	2	6908
hsa04060	Cytokine-cytokine receptor interaction	0.999999999991789	-8.21074350003392e-12	265	0	0	2	6908
ko04060	Cytokine-cytokine receptor interaction	0.999999999991789	-8.21074350003392e-12	265	0	0	2	6908
ko04922	Glucagon signaling pathway	0.999999999992038	-7.96239102754913e-12	101	0	0	2	6908
hsa04922	Glucagon signaling pathway	0.999999999992038	-7.96239102754913e-12	101	0	0	2	6908
ko05231	Choline metabolism in cancer	0.999999999992038	-7.96239102754913e-12	101	0	0	2	6908
ko04723	Retrograde endocannabinoid signaling	0.999999999992038	-7.96239102754913e-12	101	0	0	2	6908
hsa04723	Retrograde endocannabinoid signaling	0.999999999992038	-7.96239102754913e-12	101	0	0	2	6908
hsa05231	Choline metabolism in cancer	0.999999999992038	-7.96239102754913e-12	101	0	0	2	6908
hsa04727	GABAergic synapse	0.999999999992368	-7.63177178788113e-12	88	0	0	2	6908
ko04727	GABAergic synapse	0.999999999992368	-7.63177178788113e-12	88	0	0	2	6908
hsa04540	Gap junction	0.999999999992368	-7.63177178788113e-12	88	0	0	2	6908
ko04540	Gap junction	0.999999999992368	-7.63177178788113e-12	88	0	0	2	6908
hsa04022	cGMP-PKG signaling pathway	0.999999999992421	-7.57908482067887e-12	167	0	0	2	6908
ko04022	cGMP-PKG signaling pathway	0.999999999992421	-7.57908482067887e-12	167	0	0	2	6908
ko00534	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	0.999999999992494	-7.50577579960738e-12	24	0	0	2	6908
hsa00534	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	0.999999999992494	-7.50577579960738e-12	24	0	0	2	6908
hsa04977	Vitamin digestion and absorption	0.999999999992494	-7.50577579960738e-12	24	0	0	2	6908
ko04977	Vitamin digestion and absorption	0.999999999992494	-7.50577579960738e-12	24	0	0	2	6908
ko00140	Steroid hormone biosynthesis	0.999999999992579	-7.42131448525432e-12	58	0	0	2	6908
hsa05416	Viral myocarditis	0.999999999992579	-7.42131448525432e-12	58	0	0	2	6908
hsa00140	Steroid hormone biosynthesis	0.999999999992579	-7.42131448525432e-12	58	0	0	2	6908
ko03015	mRNA surveillance pathway	0.999999999992784	-7.21576707348077e-12	91	0	0	2	6908
hsa04064	NF-kappa B signaling pathway	0.999999999992784	-7.21576707348077e-12	91	0	0	2	6908
hsa05032	Morphine addiction	0.999999999992784	-7.21576707348077e-12	91	0	0	2	6908
ko04912	GnRH signaling pathway	0.999999999992784	-7.21576707348077e-12	91	0	0	2	6908
hsa04912	GnRH signaling pathway	0.999999999992784	-7.21576707348077e-12	91	0	0	2	6908
ko05032	Morphine addiction	0.999999999992784	-7.21576707348077e-12	91	0	0	2	6908
hsa03015	mRNA surveillance pathway	0.999999999992784	-7.21576707348077e-12	91	0	0	2	6908
hsa00591	Linoleic acid metabolism	0.99999999999285	-7.15027191101891e-12	29	0	0	2	6908
ko05216	Thyroid cancer	0.99999999999285	-7.15027191101891e-12	29	0	0	2	6908
ko00030	Pentose phosphate pathway	0.99999999999285	-7.15027191101891e-12	29	0	0	2	6908
hsa03440	Homologous recombination	0.99999999999285	-7.15027191101891e-12	29	0	0	2	6908
ko03440	Homologous recombination	0.99999999999285	-7.15027191101891e-12	29	0	0	2	6908
ko00591	Linoleic acid metabolism	0.99999999999285	-7.15027191101891e-12	29	0	0	2	6908
ko00760	Nicotinate and nicotinamide metabolism	0.99999999999285	-7.15027191101891e-12	29	0	0	2	6908
hsa00030	Pentose phosphate pathway	0.99999999999285	-7.15027191101891e-12	29	0	0	2	6908
hsa00760	Nicotinate and nicotinamide metabolism	0.99999999999285	-7.15027191101891e-12	29	0	0	2	6908
hsa05216	Thyroid cancer	0.99999999999285	-7.15027191101891e-12	29	0	0	2	6908
ko00232	Caffeine metabolism	0.99999999999285	-7.14955724618673e-12	5	0	0	2	6908
hsa00400	Phenylalanine, tyrosine and tryptophan biosynthesis	0.99999999999285	-7.14955724618673e-12	5	0	0	2	6908
hsa00524	Butirosin and neomycin biosynthesis	0.99999999999285	-7.14955724618673e-12	5	0	0	2	6908
ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	0.99999999999285	-7.14955724618673e-12	5	0	0	2	6908
ko00524	Butirosin and neomycin biosynthesis	0.99999999999285	-7.14955724618673e-12	5	0	0	2	6908
hsa00232	Caffeine metabolism	0.99999999999285	-7.14955724618673e-12	5	0	0	2	6908
ko00350	Tyrosine metabolism	0.999999999993043	-6.95653844045522e-12	35	0	0	2	6908
ko05020	Prion diseases	0.999999999993043	-6.95653844045522e-12	35	0	0	2	6908
hsa00350	Tyrosine metabolism	0.999999999993043	-6.95653844045522e-12	35	0	0	2	6908
hsa00250	Alanine, aspartate and glutamate metabolism	0.999999999993043	-6.95653844045522e-12	35	0	0	2	6908
hsa05020	Prion diseases	0.999999999993043	-6.95653844045522e-12	35	0	0	2	6908
ko00250	Alanine, aspartate and glutamate metabolism	0.999999999993043	-6.95653844045522e-12	35	0	0	2	6908
ko05152	Tuberculosis	0.999999999993724	-6.27614420937311e-12	177	0	0	2	6908
hsa05152	Tuberculosis	0.999999999993724	-6.27614420937311e-12	177	0	0	2	6908
hsa04380	Osteoclast differentiation	0.999999999993856	-6.14393442805589e-12	131	0	0	2	6908
ko04380	Osteoclast differentiation	0.999999999993856	-6.14393442805589e-12	131	0	0	2	6908
hsa05322	Systemic lupus erythematosus	0.999999999993864	-6.13558992024546e-12	134	0	0	2	6908
ko05162	Measles	0.999999999993864	-6.13558992024546e-12	134	0	0	2	6908
hsa05162	Measles	0.999999999993864	-6.13558992024546e-12	134	0	0	2	6908
hsa04650	Natural killer cell mediated cytotoxicity	0.999999999993864	-6.13558992024546e-12	134	0	0	2	6908
hsa04068	FoxO signaling pathway	0.999999999993864	-6.13558992024546e-12	134	0	0	2	6908
ko04650	Natural killer cell mediated cytotoxicity	0.999999999993864	-6.13558992024546e-12	134	0	0	2	6908
ko05322	Systemic lupus erythematosus	0.999999999993864	-6.13558992024546e-12	134	0	0	2	6908
ko05211	Renal cell carcinoma	0.999999999994023	-5.97722971107644e-12	66	0	0	2	6908
ko05212	Pancreatic cancer	0.999999999994023	-5.97722971107644e-12	66	0	0	2	6908
hsa05212	Pancreatic cancer	0.999999999994023	-5.97722971107644e-12	66	0	0	2	6908
hsa04720	Long-term potentiation	0.999999999994023	-5.97722971107644e-12	66	0	0	2	6908
ko04720	Long-term potentiation	0.999999999994023	-5.97722971107644e-12	66	0	0	2	6908
hsa05211	Renal cell carcinoma	0.999999999994023	-5.97722971107644e-12	66	0	0	2	6908
ko04728	Dopaminergic synapse	0.999999999994104	-5.89593342681036e-12	129	0	0	2	6908
hsa05012	Parkinson's disease	0.999999999994104	-5.89593342681036e-12	129	0	0	2	6908
hsa04728	Dopaminergic synapse	0.999999999994104	-5.89593342681036e-12	129	0	0	2	6908
ko04973	Carbohydrate digestion and absorption	0.999999999994322	-5.67807734559939e-12	45	0	0	2	6908
ko00565	Ether lipid metabolism	0.999999999994322	-5.67807734559939e-12	45	0	0	2	6908
hsa00565	Ether lipid metabolism	0.999999999994322	-5.67807734559939e-12	45	0	0	2	6908
hsa04973	Carbohydrate digestion and absorption	0.999999999994322	-5.67807734559939e-12	45	0	0	2	6908
hsa03022	Basal transcription factors	0.999999999994322	-5.67807734559939e-12	45	0	0	2	6908
ko03022	Basal transcription factors	0.999999999994322	-5.67807734559939e-12	45	0	0	2	6908
ko04915	Estrogen signaling pathway	0.999999999994404	-5.59604475930918e-12	99	0	0	2	6908
hsa04915	Estrogen signaling pathway	0.999999999994404	-5.59604475930918e-12	99	0	0	2	6908
ko05168	Herpes simplex infection	0.999999999994519	-5.48143084741493e-12	184	0	0	2	6908
hsa05168	Herpes simplex infection	0.999999999994519	-5.48143084741493e-12	184	0	0	2	6908
hsa00564	Glycerophospholipid metabolism	0.999999999994611	-5.38897615767753e-12	95	0	0	2	6908
ko04972	Pancreatic secretion	0.999999999994611	-5.38897615767753e-12	95	0	0	2	6908
hsa04972	Pancreatic secretion	0.999999999994611	-5.38897615767753e-12	95	0	0	2	6908
ko04713	Circadian entrainment	0.999999999994611	-5.38897615767753e-12	95	0	0	2	6908
hsa04713	Circadian entrainment	0.999999999994611	-5.38897615767753e-12	95	0	0	2	6908
ko00564	Glycerophospholipid metabolism	0.999999999994611	-5.38897615767753e-12	95	0	0	2	6908
hsa00300	Lysine biosynthesis	0.999999999995022	-4.97843897396992e-12	2	0	0	2	6908
ko00300	Lysine biosynthesis	0.999999999995022	-4.97843897396992e-12	2	0	0	2	6908
ko04024	cAMP signaling pathway	0.999999999995036	-4.96438729968157e-12	199	0	0	2	6908
ko05169	Epstein-Barr virus infection	0.999999999995036	-4.96438729968157e-12	199	0	0	2	6908
hsa05169	Epstein-Barr virus infection	0.999999999995036	-4.96438729968157e-12	199	0	0	2	6908
hsa04024	cAMP signaling pathway	0.999999999995036	-4.96438729968157e-12	199	0	0	2	6908
ko00860	Porphyrin and chlorophyll metabolism	0.999999999995189	-4.81089988809899e-12	42	0	0	2	6908
hsa00860	Porphyrin and chlorophyll metabolism	0.999999999995189	-4.81089988809899e-12	42	0	0	2	6908
hsa04015	Rap1 signaling pathway	0.999999999995233	-4.76739199332943e-12	211	0	0	2	6908
ko04015	Rap1 signaling pathway	0.999999999995233	-4.76739199332943e-12	211	0	0	2	6908
hsa04310	Wnt signaling pathway	0.999999999995332	-4.66804329565806e-12	141	0	0	2	6908
ko04310	Wnt signaling pathway	0.999999999995332	-4.66804329565806e-12	141	0	0	2	6908
hsa04012	ErbB signaling pathway	0.999999999995338	-4.66186502378826e-12	87	0	0	2	6908
hsa04512	ECM-receptor interaction	0.999999999995338	-4.66186502378826e-12	87	0	0	2	6908
ko04640	Hematopoietic cell lineage	0.999999999995338	-4.66186502378826e-12	87	0	0	2	6908
ko04012	ErbB signaling pathway	0.999999999995338	-4.66186502378826e-12	87	0	0	2	6908
hsa04914	Progesterone-mediated oocyte maturation	0.999999999995338	-4.66186502378826e-12	87	0	0	2	6908
ko04914	Progesterone-mediated oocyte maturation	0.999999999995338	-4.66186502378826e-12	87	0	0	2	6908
hsa04640	Hematopoietic cell lineage	0.999999999995338	-4.66186502378826e-12	87	0	0	2	6908
ko04512	ECM-receptor interaction	0.999999999995338	-4.66186502378826e-12	87	0	0	2	6908
hsa05120	Epithelial cell signaling in Helicobacter pylori infection	0.999999999995621	-4.37881930151138e-12	68	0	0	2	6908
hsa04115	p53 signaling pathway	0.999999999995621	-4.37881930151138e-12	68	0	0	2	6908
ko00982	Drug metabolism - cytochrome P450	0.999999999995621	-4.37881930151138e-12	68	0	0	2	6908
hsa00982	Drug metabolism - cytochrome P450	0.999999999995621	-4.37881930151138e-12	68	0	0	2	6908
ko04115	p53 signaling pathway	0.999999999995621	-4.37881930151138e-12	68	0	0	2	6908
ko05120	Epithelial cell signaling in Helicobacter pylori infection	0.999999999995621	-4.37881930151138e-12	68	0	0	2	6908
ko05210	Colorectal cancer	0.99999999999585	-4.15033692092656e-12	62	0	0	2	6908
hsa00590	Arachidonic acid metabolism	0.99999999999585	-4.15033692092656e-12	62	0	0	2	6908
hsa05210	Colorectal cancer	0.99999999999585	-4.15033692092656e-12	62	0	0	2	6908
ko00590	Arachidonic acid metabolism	0.99999999999585	-4.15033692092656e-12	62	0	0	2	6908
hsa04925	Aldosterone synthesis and secretion	0.999999999996056	-3.94416289450743e-12	81	0	0	2	6908
hsa05204	Chemical carcinogenesis	0.999999999996056	-3.94416289450743e-12	81	0	0	2	6908
ko05204	Chemical carcinogenesis	0.999999999996056	-3.94416289450743e-12	81	0	0	2	6908
ko04925	Aldosterone synthesis and secretion	0.999999999996056	-3.94416289450743e-12	81	0	0	2	6908
hsa04066	HIF-1 signaling pathway	0.999999999996103	-3.89672652869114e-12	103	0	0	2	6908
hsa05010	Alzheimer's disease	0.999999999996155	-3.84479535882332e-12	162	0	0	2	6908
ko05010	Alzheimer's disease	0.999999999996155	-3.84479535882332e-12	162	0	0	2	6908
hsa00910	Nitrogen metabolism	0.999999999996168	-3.83251465671975e-12	17	0	0	2	6908
hsa00450	Selenocompound metabolism	0.999999999996168	-3.83251465671975e-12	17	0	0	2	6908
ko00120	Primary bile acid biosynthesis	0.999999999996168	-3.83251465671975e-12	17	0	0	2	6908
ko01210	2-Oxocarboxylic acid metabolism	0.999999999996168	-3.83251465671975e-12	17	0	0	2	6908
hsa00360	Phenylalanine metabolism	0.999999999996168	-3.83251465671975e-12	17	0	0	2	6908
hsa01210	2-Oxocarboxylic acid metabolism	0.999999999996168	-3.83251465671975e-12	17	0	0	2	6908
ko00360	Phenylalanine metabolism	0.999999999996168	-3.83251465671975e-12	17	0	0	2	6908
ko00910	Nitrogen metabolism	0.999999999996168	-3.83251465671975e-12	17	0	0	2	6908
ko00450	Selenocompound metabolism	0.999999999996168	-3.83251465671975e-12	17	0	0	2	6908
hsa00120	Primary bile acid biosynthesis	0.999999999996168	-3.83251465671975e-12	17	0	0	2	6908
hsa04612	Antigen processing and presentation	0.999999999996498	-3.50222821121453e-12	77	0	0	2	6908
ko03018	RNA degradation	0.999999999996498	-3.50222821121453e-12	77	0	0	2	6908
ko04612	Antigen processing and presentation	0.999999999996498	-3.50222821121453e-12	77	0	0	2	6908
hsa03018	RNA degradation	0.999999999996498	-3.50222821121453e-12	77	0	0	2	6908
hsa00983	Drug metabolism - other enzymes	0.999999999996545	-3.45531185586521e-12	46	0	0	2	6908
ko00983	Drug metabolism - other enzymes	0.999999999996545	-3.45531185586521e-12	46	0	0	2	6908
hsa04611	Platelet activation	0.999999999996942	-3.05759194005328e-12	130	0	0	2	6908
ko04744	Phototransduction	0.999999999997063	-2.93729896701516e-12	28	0	0	2	6908
hsa00630	Glyoxylate and dicarboxylate metabolism	0.999999999997063	-2.93729896701516e-12	28	0	0	2	6908
ko00640	Propanoate metabolism	0.999999999997063	-2.93729896701516e-12	28	0	0	2	6908
hsa04744	Phototransduction	0.999999999997063	-2.93729896701516e-12	28	0	0	2	6908
hsa00640	Propanoate metabolism	0.999999999997063	-2.93729896701516e-12	28	0	0	2	6908
ko00630	Glyoxylate and dicarboxylate metabolism	0.999999999997063	-2.93729896701516e-12	28	0	0	2	6908
ko04932	Non-alcoholic fatty liver disease (NAFLD)	0.999999999997083	-2.91683008041971e-12	147	0	0	2	6908
hsa04932	Non-alcoholic fatty liver disease (NAFLD)	0.999999999997083	-2.91683008041971e-12	147	0	0	2	6908
ko00785	Lipoic acid metabolism	0.999999999997461	-2.53898609881163e-12	3	0	0	2	6908
hsa00780	Biotin metabolism	0.999999999997461	-2.53898609881163e-12	3	0	0	2	6908
ko01220	Degradation of aromatic compounds	0.999999999997461	-2.53898609881163e-12	3	0	0	2	6908
hsa01220	Degradation of aromatic compounds	0.999999999997461	-2.53898609881163e-12	3	0	0	2	6908
hsa00785	Lipoic acid metabolism	0.999999999997461	-2.53898609881163e-12	3	0	0	2	6908
ko00780	Biotin metabolism	0.999999999997461	-2.53898609881163e-12	3	0	0	2	6908
ko04350	TGF-beta signaling pathway	0.999999999997462	-2.53798566364483e-12	84	0	0	2	6908
hsa04350	TGF-beta signaling pathway	0.999999999997462	-2.53798566364483e-12	84	0	0	2	6908
ko05133	Pertussis	0.999999999997656	-2.3444465092155e-12	75	0	0	2	6908
hsa05133	Pertussis	0.999999999997656	-2.3444465092155e-12	75	0	0	2	6908
ko04670	Leukocyte transendothelial migration	0.999999999997742	-2.25762453436723e-12	118	0	0	2	6908
hsa04670	Leukocyte transendothelial migration	0.999999999997742	-2.25762453436723e-12	118	0	0	2	6908
hsa04919	Thyroid hormone signaling pathway	0.999999999997742	-2.25762453436723e-12	118	0	0	2	6908
hsa05145	Toxoplasmosis	0.999999999997742	-2.25762453436723e-12	118	0	0	2	6908
ko05145	Toxoplasmosis	0.999999999997742	-2.25762453436723e-12	118	0	0	2	6908
hsa04340	Hedgehog signaling pathway	0.999999999997906	-2.09376285298206e-12	51	0	0	2	6908
ko04340	Hedgehog signaling pathway	0.999999999997906	-2.09376285298206e-12	51	0	0	2	6908
hsa04978	Mineral absorption	0.999999999997906	-2.09376285298206e-12	51	0	0	2	6908
hsa05014	Amyotrophic lateral sclerosis (ALS)	0.999999999997906	-2.09376285298206e-12	51	0	0	2	6908
ko04742	Taste transduction	0.999999999997906	-2.09376285298206e-12	51	0	0	2	6908
hsa00480	Glutathione metabolism	0.999999999997906	-2.09376285298206e-12	51	0	0	2	6908
ko04978	Mineral absorption	0.999999999997906	-2.09376285298206e-12	51	0	0	2	6908
ko05014	Amyotrophic lateral sclerosis (ALS)	0.999999999997906	-2.09376285298206e-12	51	0	0	2	6908
hsa04742	Taste transduction	0.999999999997906	-2.09376285298206e-12	51	0	0	2	6908
ko00480	Glutathione metabolism	0.999999999997906	-2.09376285298206e-12	51	0	0	2	6908
hsa04142	Lysosome	0.999999999998017	-1.9830246928039e-12	123	0	0	2	6908
hsa04152	AMPK signaling pathway	0.999999999998017	-1.9830246928039e-12	123	0	0	2	6908
ko04152	AMPK signaling pathway	0.999999999998017	-1.9830246928039e-12	123	0	0	2	6908
ko04142	Lysosome	0.999999999998017	-1.9830246928039e-12	123	0	0	2	6908
ko05033	Nicotine addiction	0.999999999998256	-1.74428201239361e-12	40	0	0	2	6908
ko00380	Tryptophan metabolism	0.999999999998256	-1.74428201239361e-12	40	0	0	2	6908
hsa05033	Nicotine addiction	0.999999999998256	-1.74428201239361e-12	40	0	0	2	6908
ko00620	Pyruvate metabolism	0.999999999998256	-1.74428201239361e-12	40	0	0	2	6908
hsa00620	Pyruvate metabolism	0.999999999998256	-1.74428201239361e-12	40	0	0	2	6908
hsa00380	Tryptophan metabolism	0.999999999998256	-1.74428201239361e-12	40	0	0	2	6908
ko04140	Regulation of autophagy	0.999999999998391	-1.60860786632211e-12	39	0	0	2	6908
ko04960	Aldosterone-regulated sodium reabsorption	0.999999999998391	-1.60860786632211e-12	39	0	0	2	6908
hsa04140	Regulation of autophagy	0.999999999998391	-1.60860786632211e-12	39	0	0	2	6908
ko00260	Glycine, serine and threonine metabolism	0.999999999998391	-1.60860786632211e-12	39	0	0	2	6908
hsa00260	Glycine, serine and threonine metabolism	0.999999999998391	-1.60860786632211e-12	39	0	0	2	6908
hsa04960	Aldosterone-regulated sodium reabsorption	0.999999999998391	-1.60860786632211e-12	39	0	0	2	6908
ko04080	Neuroactive ligand-receptor interaction	0.999999999998477	-1.52313274839888e-12	276	0	0	2	6908
hsa04080	Neuroactive ligand-receptor interaction	0.999999999998477	-1.52313274839888e-12	276	0	0	2	6908
hsa04913	Ovarian steroidogenesis	0.99999999999854	-1.45966295691038e-12	50	0	0	2	6908
ko04913	Ovarian steroidogenesis	0.99999999999854	-1.45966295691038e-12	50	0	0	2	6908
ko05034	Alcoholism	0.99999999999859	-1.40958826642251e-12	179	0	0	2	6908
hsa05202	Transcriptional misregulation in cancer	0.99999999999859	-1.40958826642251e-12	179	0	0	2	6908
ko04020	Calcium signaling pathway	0.99999999999859	-1.40958826642251e-12	179	0	0	2	6908
hsa05034	Alcoholism	0.99999999999859	-1.40958826642251e-12	179	0	0	2	6908
ko05202	Transcriptional misregulation in cancer	0.99999999999859	-1.40958826642251e-12	179	0	0	2	6908
hsa04020	Calcium signaling pathway	0.99999999999859	-1.40958826642251e-12	179	0	0	2	6908
ko04921	Oxytocin signaling pathway	0.999999999998605	-1.39508099083335e-12	157	0	0	2	6908
hsa04921	Oxytocin signaling pathway	0.999999999998605	-1.39508099083335e-12	157	0	0	2	6908
hsa04924	Renin secretion	0.999999999998605	-1.39500780718671e-12	64	0	0	2	6908
ko04924	Renin secretion	0.999999999998605	-1.39500780718671e-12	64	0	0	2	6908
hsa05131	Shigellosis	0.999999999998605	-1.39500780718671e-12	64	0	0	2	6908
ko00790	Folate biosynthesis	0.999999999998949	-1.05122981750949e-12	14	0	0	2	6908
hsa00790	Folate biosynthesis	0.999999999998949	-1.05122981750949e-12	14	0	0	2	6908
hsa00603	Glycosphingolipid biosynthesis - globo series	0.999999999998949	-1.05122981750949e-12	14	0	0	2	6908
ko00603	Glycosphingolipid biosynthesis - globo series	0.999999999998949	-1.05122981750949e-12	14	0	0	2	6908
hsa05140	Leishmaniasis	0.999999999999309	-6.90767145631981e-13	72	0	0	2	6908
ko05140	Leishmaniasis	0.999999999999309	-6.90767145631981e-13	72	0	0	2	6908
hsa04662	B cell receptor signaling pathway	0.999999999999309	-6.90767145631981e-13	72	0	0	2	6908
hsa04917	Prolactin signaling pathway	0.999999999999309	-6.90767145631981e-13	72	0	0	2	6908
ko04917	Prolactin signaling pathway	0.999999999999309	-6.90767145631981e-13	72	0	0	2	6908
ko04662	B cell receptor signaling pathway	0.999999999999309	-6.90767145631981e-13	72	0	0	2	6908
ko04630	Jak-STAT signaling pathway	0.999999999999461	-5.39033661456356e-13	158	0	0	2	6908
hsa04630	Jak-STAT signaling pathway	0.999999999999461	-5.39033661456356e-13	158	0	0	2	6908
hsa05205	Proteoglycans in cancer	0.999999999999561	-4.39101771436412e-13	203	0	0	2	6908
ko05205	Proteoglycans in cancer	0.999999999999561	-4.39101771436412e-13	203	0	0	2	6908
hsa00270	Cysteine and methionine metabolism	0.999999999999718	-2.82175565330172e-13	37	0	0	2	6908
ko00270	Cysteine and methionine metabolism	0.999999999999718	-2.82175565330172e-13	37	0	0	2	6908
hsa05330	Allograft rejection	0.999999999999718	-2.82175565330172e-13	37	0	0	2	6908
ko05330	Allograft rejection	0.999999999999718	-2.82175565330172e-13	37	0	0	2	6908
ko04261	Adrenergic signaling in cardiomyocytes	0.999999999999915	-8.53819510752973e-14	148	0	0	2	6908
hsa04261	Adrenergic signaling in cardiomyocytes	0.999999999999915	-8.53819510752973e-14	148	0	0	2	6908
ko04660	T cell receptor signaling pathway	0.999999999999963	-3.66327248483428e-14	104	0	0	2	6908
hsa05142	Chagas disease (American trypanosomiasis)	0.999999999999963	-3.66327248483428e-14	104	0	0	2	6908
hsa00240	Pyrimidine metabolism	0.999999999999963	-3.66327248483428e-14	104	0	0	2	6908
ko05142	Chagas disease (American trypanosomiasis)	0.999999999999963	-3.66327248483428e-14	104	0	0	2	6908
hsa04660	T cell receptor signaling pathway	0.999999999999963	-3.66327248483428e-14	104	0	0	2	6908
ko00240	Pyrimidine metabolism	0.999999999999963	-3.66327248483428e-14	104	0	0	2	6908
hsa04910	Insulin signaling pathway	1.00000000000014	1.36303674510424e-13	139	0	0	2	6908
ko04910	Insulin signaling pathway	1.00000000000014	1.36303674510424e-13	139	0	0	2	6908
hsa04664	Fc epsilon RI signaling pathway	1.00000000000017	1.65397792575676e-13	70	0	0	2	6908
ko04920	Adipocytokine signaling pathway	1.00000000000017	1.65397792575676e-13	70	0	0	2	6908
hsa04622	RIG-I-like receptor signaling pathway	1.00000000000017	1.65397792575676e-13	70	0	0	2	6908
ko04622	RIG-I-like receptor signaling pathway	1.00000000000017	1.65397792575676e-13	70	0	0	2	6908
ko04664	Fc epsilon RI signaling pathway	1.00000000000017	1.65397792575676e-13	70	0	0	2	6908
hsa04920	Adipocytokine signaling pathway	1.00000000000017	1.65397792575676e-13	70	0	0	2	6908
ko04514	Cell adhesion molecules (CAMs)	1.00000000000018	1.83497151935025e-13	142	0	0	2	6908
hsa04550	Signaling pathways regulating pluripotency of stem cells	1.00000000000018	1.83497151935025e-13	142	0	0	2	6908
ko04550	Signaling pathways regulating pluripotency of stem cells	1.00000000000018	1.83497151935025e-13	142	0	0	2	6908
hsa04514	Cell adhesion molecules (CAMs)	1.00000000000018	1.83497151935025e-13	142	0	0	2	6908
ko05332	Graft-versus-host disease	1.0000000000002	1.99990164131882e-13	41	0	0	2	6908
hsa04975	Fat digestion and absorption	1.0000000000002	1.99990164131882e-13	41	0	0	2	6908
hsa05332	Graft-versus-host disease	1.0000000000002	1.99990164131882e-13	41	0	0	2	6908
ko05219	Bladder cancer	1.0000000000002	1.99990164131882e-13	41	0	0	2	6908
ko04975	Fat digestion and absorption	1.0000000000002	1.99990164131882e-13	41	0	0	2	6908
hsa05219	Bladder cancer	1.0000000000002	1.99990164131882e-13	41	0	0	2	6908
hsa03008	Ribosome biogenesis in eukaryotes	1.00000000000021	2.11472034545093e-13	78	0	0	2	6908
hsa05100	Bacterial invasion of epithelial cells	1.00000000000021	2.11472034545093e-13	78	0	0	2	6908
ko03008	Ribosome biogenesis in eukaryotes	1.00000000000021	2.11472034545093e-13	78	0	0	2	6908
ko05100	Bacterial invasion of epithelial cells	1.00000000000021	2.11472034545093e-13	78	0	0	2	6908
hsa00531	Glycosaminoglycan degradation	1.00000000000035	3.53184179595161e-13	19	0	0	2	6908
ko00531	Glycosaminoglycan degradation	1.00000000000035	3.53184179595161e-13	19	0	0	2	6908
hsa04621	NOD-like receptor signaling pathway	1.00000000000081	8.13656149292567e-13	57	0	0	2	6908
hsa05221	Acute myeloid leukemia	1.00000000000081	8.13656149292567e-13	57	0	0	2	6908
ko05221	Acute myeloid leukemia	1.00000000000081	8.13656149292567e-13	57	0	0	2	6908
ko04621	NOD-like receptor signaling pathway	1.00000000000081	8.13656149292567e-13	57	0	0	2	6908
ko05410	Hypertrophic cardiomyopathy (HCM)	1.00000000000103	1.02671086151147e-12	83	0	0	2	6908
hsa04146	Peroxisome	1.00000000000103	1.02671086151147e-12	83	0	0	2	6908
hsa05410	Hypertrophic cardiomyopathy (HCM)	1.00000000000103	1.02671086151147e-12	83	0	0	2	6908
ko04146	Peroxisome	1.00000000000103	1.02671086151147e-12	83	0	0	2	6908
ko00051	Fructose and mannose metabolism	1.00000000000104	1.03842624196758e-12	32	0	0	2	6908
hsa00051	Fructose and mannose metabolism	1.00000000000104	1.03842624196758e-12	32	0	0	2	6908
ko05143	African trypanosomiasis	1.00000000000119	1.18506590377951e-12	34	0	0	2	6908
hsa05143	African trypanosomiasis	1.00000000000119	1.18506590377951e-12	34	0	0	2	6908
ko04130	SNARE interactions in vesicular transport	1.00000000000119	1.18506590377951e-12	34	0	0	2	6908
hsa04130	SNARE interactions in vesicular transport	1.00000000000119	1.18506590377951e-12	34	0	0	2	6908
hsa05161	Hepatitis B	1.00000000000129	1.28728072038703e-12	146	0	0	2	6908
hsa03460	Fanconi anemia pathway	1.0000000000013	1.29736041245936e-12	53	0	0	2	6908
ko05110	Vibrio cholerae infection	1.0000000000013	1.29736041245936e-12	53	0	0	2	6908
hsa05110	Vibrio cholerae infection	1.0000000000013	1.29736041245936e-12	53	0	0	2	6908
ko03460	Fanconi anemia pathway	1.0000000000013	1.29736041245936e-12	53	0	0	2	6908
hsa00280	Valine, leucine and isoleucine degradation	1.0000000000023	2.29762588891801e-12	47	0	0	2	6908
ko04672	Intestinal immune network for IgA production	1.0000000000023	2.29762588891801e-12	47	0	0	2	6908
ko04961	Endocrine and other factor-regulated calcium reabsorption	1.0000000000023	2.29762588891801e-12	47	0	0	2	6908
hsa04672	Intestinal immune network for IgA production	1.0000000000023	2.29762588891801e-12	47	0	0	2	6908
ko00600	Sphingolipid metabolism	1.0000000000023	2.29762588891801e-12	47	0	0	2	6908
hsa03420	Nucleotide excision repair	1.0000000000023	2.29762588891801e-12	47	0	0	2	6908
ko00280	Valine, leucine and isoleucine degradation	1.0000000000023	2.29762588891801e-12	47	0	0	2	6908
hsa00600	Sphingolipid metabolism	1.0000000000023	2.29762588891801e-12	47	0	0	2	6908
ko03420	Nucleotide excision repair	1.0000000000023	2.29762588891801e-12	47	0	0	2	6908
hsa04961	Endocrine and other factor-regulated calcium reabsorption	1.0000000000023	2.29762588891801e-12	47	0	0	2	6908
hsa00472	D-Arginine and D-ornithine metabolism	1.00000000000235	2.35174428759102e-12	1	0	0	2	6908
ko00472	D-Arginine and D-ornithine metabolism	1.00000000000235	2.35174428759102e-12	1	0	0	2	6908
hsa05164	Influenza A	1.0000000000025	2.50174631444972e-12	174	0	0	2	6908
ko00230	Purine metabolism	1.0000000000025	2.50174631444972e-12	174	0	0	2	6908
ko05164	Influenza A	1.0000000000025	2.50174631444972e-12	174	0	0	2	6908
hsa00230	Purine metabolism	1.0000000000025	2.50174631444972e-12	174	0	0	2	6908
ko04721	Synaptic vesicle cycle	1.00000000000252	2.5177041712305e-12	63	0	0	2	6908
hsa04623	Cytosolic DNA-sensing pathway	1.00000000000252	2.5177041712305e-12	63	0	0	2	6908
ko04623	Cytosolic DNA-sensing pathway	1.00000000000252	2.5177041712305e-12	63	0	0	2	6908
hsa04721	Synaptic vesicle cycle	1.00000000000252	2.5177041712305e-12	63	0	0	2	6908
ko00520	Amino sugar and nucleotide sugar metabolism	1.00000000000259	2.58622761878033e-12	48	0	0	2	6908
ko04330	Notch signaling pathway	1.00000000000259	2.58622761878033e-12	48	0	0	2	6908
hsa01212	Fatty acid metabolism	1.00000000000259	2.58622761878033e-12	48	0	0	2	6908
hsa00520	Amino sugar and nucleotide sugar metabolism	1.00000000000259	2.58622761878033e-12	48	0	0	2	6908
ko01212	Fatty acid metabolism	1.00000000000259	2.58622761878033e-12	48	0	0	2	6908
ko04930	Type II diabetes mellitus	1.00000000000259	2.58622761878033e-12	48	0	0	2	6908
hsa04330	Notch signaling pathway	1.00000000000259	2.58622761878033e-12	48	0	0	2	6908
hsa04930	Type II diabetes mellitus	1.00000000000259	2.58622761878033e-12	48	0	0	2	6908
hsa01130	Biosynthesis of antibiotics	1.0000000000026	2.60338452184872e-12	210	0	0	2	6908
ko03013	RNA transport	1.00000000000265	2.64848993430933e-12	166	0	0	2	6908
hsa03013	RNA transport	1.00000000000265	2.64848993430933e-12	166	0	0	2	6908
ko04970	Salivary secretion	1.000000000003	2.99867560795385e-12	89	0	0	2	6908
ko05414	Dilated cardiomyopathy	1.000000000003	2.99867560795385e-12	89	0	0	2	6908
hsa05323	Rheumatoid arthritis	1.000000000003	2.99867560795385e-12	89	0	0	2	6908
hsa04974	Protein digestion and absorption	1.000000000003	2.99867560795385e-12	89	0	0	2	6908
ko04974	Protein digestion and absorption	1.000000000003	2.99867560795385e-12	89	0	0	2	6908
ko05323	Rheumatoid arthritis	1.000000000003	2.99867560795385e-12	89	0	0	2	6908
hsa05215	Prostate cancer	1.000000000003	2.99867560795385e-12	89	0	0	2	6908
hsa05414	Dilated cardiomyopathy	1.000000000003	2.99867560795385e-12	89	0	0	2	6908
ko05215	Prostate cancer	1.000000000003	2.99867560795385e-12	89	0	0	2	6908
hsa04970	Salivary secretion	1.000000000003	2.99867560795385e-12	89	0	0	2	6908
hsa05222	Small cell lung cancer	1.00000000000306	3.05537724027555e-12	86	0	0	2	6908
ko05222	Small cell lung cancer	1.00000000000306	3.05537724027555e-12	86	0	0	2	6908
hsa05223	Non-small cell lung cancer	1.00000000000351	3.50593242859441e-12	56	0	0	2	6908
ko00500	Starch and sucrose metabolism	1.00000000000351	3.50593242859441e-12	56	0	0	2	6908
hsa00500	Starch and sucrose metabolism	1.00000000000351	3.50593242859441e-12	56	0	0	2	6908
ko05223	Non-small cell lung cancer	1.00000000000351	3.50593242859441e-12	56	0	0	2	6908
hsa04923	Regulation of lipolysis in adipocytes	1.00000000000351	3.50593242859441e-12	56	0	0	2	6908
ko00514	Other types of O-glycan biosynthesis	1.00000000000421	4.21350281393424e-12	31	0	0	2	6908
hsa04710	Circadian rhythm	1.00000000000421	4.21350281393424e-12	31	0	0	2	6908
ko04710	Circadian rhythm	1.00000000000421	4.21350281393424e-12	31	0	0	2	6908
ko00512	Mucin type O-Glycan biosynthesis	1.00000000000421	4.21350281393424e-12	31	0	0	2	6908
hsa00512	Mucin type O-Glycan biosynthesis	1.00000000000421	4.21350281393424e-12	31	0	0	2	6908
hsa00514	Other types of O-glycan biosynthesis	1.00000000000421	4.21350281393424e-12	31	0	0	2	6908
ko00410	beta-Alanine metabolism	1.00000000000421	4.21350281393424e-12	31	0	0	2	6908
ko03020	RNA polymerase	1.00000000000421	4.21350281393424e-12	31	0	0	2	6908
hsa03020	RNA polymerase	1.00000000000421	4.21350281393424e-12	31	0	0	2	6908
hsa00410	beta-Alanine metabolism	1.00000000000421	4.21350281393424e-12	31	0	0	2	6908
ko04520	Adherens junction	1.00000000000437	4.36650097589836e-12	73	0	0	2	6908
hsa01230	Biosynthesis of amino acids	1.00000000000437	4.36650097589836e-12	73	0	0	2	6908
hsa04520	Adherens junction	1.00000000000437	4.36650097589836e-12	73	0	0	2	6908
ko01230	Biosynthesis of amino acids	1.00000000000437	4.36650097589836e-12	73	0	0	2	6908
hsa00340	Histidine metabolism	1.00000000000447	4.47361798382965e-12	23	0	0	2	6908
hsa04964	Proximal tubule bicarbonate reclamation	1.00000000000447	4.47361798382965e-12	23	0	0	2	6908
hsa03060	Protein export	1.00000000000447	4.47361798382965e-12	23	0	0	2	6908
ko03430	Mismatch repair	1.00000000000447	4.47361798382965e-12	23	0	0	2	6908
ko03060	Protein export	1.00000000000447	4.47361798382965e-12	23	0	0	2	6908
ko01040	Biosynthesis of unsaturated fatty acids	1.00000000000447	4.47361798382965e-12	23	0	0	2	6908
ko04964	Proximal tubule bicarbonate reclamation	1.00000000000447	4.47361798382965e-12	23	0	0	2	6908
hsa04614	Renin-angiotensin system	1.00000000000447	4.47361798382965e-12	23	0	0	2	6908
ko04614	Renin-angiotensin system	1.00000000000447	4.47361798382965e-12	23	0	0	2	6908
hsa01040	Biosynthesis of unsaturated fatty acids	1.00000000000447	4.47361798382965e-12	23	0	0	2	6908
hsa03430	Mismatch repair	1.00000000000447	4.47361798382965e-12	23	0	0	2	6908
ko00340	Histidine metabolism	1.00000000000447	4.47361798382965e-12	23	0	0	2	6908
hsa04390	Hippo signaling pathway	1.00000000000482	4.81981978200235e-12	154	0	0	2	6908
ko04390	Hippo signaling pathway	1.00000000000482	4.81981978200235e-12	154	0	0	2	6908
hsa04931	Insulin resistance	1.00000000000513	5.12561423426233e-12	111	0	0	2	6908
hsa04725	Cholinergic synapse	1.00000000000513	5.12561423426233e-12	111	0	0	2	6908
ko00533	Glycosaminoglycan biosynthesis - keratan sulfate	1.00000000000536	5.35837143088975e-12	15	0	0	2	6908
hsa00604	Glycosphingolipid biosynthesis - ganglio series	1.00000000000536	5.35837143088975e-12	15	0	0	2	6908
hsa00533	Glycosaminoglycan biosynthesis - keratan sulfate	1.00000000000536	5.35837143088975e-12	15	0	0	2	6908
ko00604	Glycosphingolipid biosynthesis - ganglio series	1.00000000000536	5.35837143088975e-12	15	0	0	2	6908
hsa00460	Cyanoamino acid metabolism	1.00000000000576	5.7649848983039e-12	7	0	0	2	6908
ko00460	Cyanoamino acid metabolism	1.00000000000576	5.7649848983039e-12	7	0	0	2	6908
ko04810	Regulation of actin cytoskeleton	1.00000000000638	6.38081720707312e-12	214	0	0	2	6908
hsa04810	Regulation of actin cytoskeleton	1.00000000000638	6.38081720707312e-12	214	0	0	2	6908
hsa04510	Focal adhesion	1.00000000000725	7.24566359602136e-12	207	0	0	2	6908
ko04510	Focal adhesion	1.00000000000725	7.24566359602136e-12	207	0	0	2	6908
hsa00601	Glycosphingolipid biosynthesis - lacto and neolacto series	1.00000000000748	7.48046413427315e-12	26	0	0	2	6908
hsa04950	Maturity onset diabetes of the young	1.00000000000748	7.48046413427315e-12	26	0	0	2	6908
ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	1.00000000000748	7.48046413427315e-12	26	0	0	2	6908
ko04950	Maturity onset diabetes of the young	1.00000000000748	7.48046413427315e-12	26	0	0	2	6908
hsa04726	Serotonergic synapse	1.00000000000761	7.6069811799466e-12	112	0	0	2	6908
hsa04114	Oocyte meiosis	1.00000000000761	7.6069811799466e-12	112	0	0	2	6908
ko04114	Oocyte meiosis	1.00000000000761	7.6069811799466e-12	112	0	0	2	6908
ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1.00000000000794	7.93586120644048e-12	11	0	0	2	6908
hsa00430	Taurine and hypotaurine metabolism	1.00000000000794	7.93586120644048e-12	11	0	0	2	6908
hsa00130	Ubiquinone and other terpenoid-quinone biosynthesis	1.00000000000794	7.93586120644048e-12	11	0	0	2	6908
ko00430	Taurine and hypotaurine metabolism	1.00000000000794	7.93586120644048e-12	11	0	0	2	6908
ko04320	Dorso-ventral axis formation	1.00000000000844	8.43611840133833e-12	27	0	0	2	6908
hsa00053	Ascorbate and aldarate metabolism	1.00000000000844	8.43611840133833e-12	27	0	0	2	6908
ko00053	Ascorbate and aldarate metabolism	1.00000000000844	8.43611840133833e-12	27	0	0	2	6908
hsa04320	Dorso-ventral axis formation	1.00000000000844	8.43611840133833e-12	27	0	0	2	6908
hsa00650	Butanoate metabolism	1.00000000000844	8.43611840133833e-12	27	0	0	2	6908
ko00650	Butanoate metabolism	1.00000000000844	8.43611840133833e-12	27	0	0	2	6908
ko04966	Collecting duct acid secretion	1.00000000000844	8.43611840133833e-12	27	0	0	2	6908
hsa04966	Collecting duct acid secretion	1.00000000000844	8.43611840133833e-12	27	0	0	2	6908
hsa00670	One carbon pool by folate	1.0000000000091	9.09532669347163e-12	20	0	0	2	6908
ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	1.0000000000091	9.09532669347163e-12	20	0	0	2	6908
hsa00100	Steroid biosynthesis	1.0000000000091	9.09532669347163e-12	20	0	0	2	6908
ko00220	Arginine biosynthesis	1.0000000000091	9.09532669347163e-12	20	0	0	2	6908
hsa00220	Arginine biosynthesis	1.0000000000091	9.09532669347163e-12	20	0	0	2	6908
hsa00532	Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	1.0000000000091	9.09532669347163e-12	20	0	0	2	6908
ko00670	One carbon pool by folate	1.0000000000091	9.09532669347163e-12	20	0	0	2	6908
ko00100	Steroid biosynthesis	1.0000000000091	9.09532669347163e-12	20	0	0	2	6908
hsa04151	PI3K-Akt signaling pathway	1.00000000000936	9.36310230736925e-12	346	0	0	2	6908
ko04151	PI3K-Akt signaling pathway	1.00000000000936	9.36310230736925e-12	346	0	0	2	6908
hsa04916	Melanogenesis	1.00000000000996	9.9593752841097e-12	100	0	0	2	6908
ko04916	Melanogenesis	1.00000000000996	9.9593752841097e-12	100	0	0	2	6908
hsa00750	Vitamin B6 metabolism	1.00000000001014	1.01366870771561e-11	6	0	0	2	6908
ko00750	Vitamin B6 metabolism	1.00000000001014	1.01366870771561e-11	6	0	0	2	6908
ko00010	Glycolysis / Gluconeogenesis	1.00000000001132	1.13193614637713e-11	67	0	0	2	6908
hsa05031	Amphetamine addiction	1.00000000001132	1.13193614637713e-11	67	0	0	2	6908
hsa00010	Glycolysis / Gluconeogenesis	1.00000000001132	1.13193614637713e-11	67	0	0	2	6908
ko05230	Central carbon metabolism in cancer	1.00000000001132	1.13193614637713e-11	67	0	0	2	6908
hsa05230	Central carbon metabolism in cancer	1.00000000001132	1.13193614637713e-11	67	0	0	2	6908
ko05031	Amphetamine addiction	1.00000000001132	1.13193614637713e-11	67	0	0	2	6908
hsa04360	Axon guidance	1.00000000001221	1.22094511150611e-11	127	0	0	2	6908
ko04360	Axon guidance	1.00000000001221	1.22094511150611e-11	127	0	0	2	6908
